Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis
- PMID: 29453889
- DOI: 10.1002/1873-3468.13013
Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis
Abstract
The neuron is the target of inflammatory demyelinating processes in multiple sclerosis (MS). In progressive MS, however, there is a gathering body of evidence indicating that molecular changes converge on mitochondria within neuronal cell bodies. The most reproducible change relates to mitochondrial respiratory chain complex deficiency, which compromises the capacity of neurons to generate ATP. The resulting energy failure state is coupled with an increase in demand for energy by the demyelinated axon, being particularly relevant to the long tracts such as corticospinal tracts with long projection axons. Recent work in our laboratory and that of our collaborators indicates the limited reflection of the mitochondria changes within neurons in experimental disease models. The mitochondrial changes within neuronal compartments are likely to offer novel targets for the improvement in neuronal function in patients with progressive MS.
Keywords: demyelination; mitochondria; multiple sclerosis; neurodegeneration; progression.
© 2018 Federation of European Biochemical Societies.
Similar articles
-
Targeting mitochondria to protect axons in progressive MS.Neurosci Lett. 2019 Sep 25;710:134258. doi: 10.1016/j.neulet.2019.05.012. Epub 2019 May 10. Neurosci Lett. 2019. PMID: 31082453 Review.
-
Neurodegeneration in Progressive Multiple Sclerosis.Cold Spring Harb Perspect Med. 2018 Oct 1;8(10):a028985. doi: 10.1101/cshperspect.a028985. Cold Spring Harb Perspect Med. 2018. PMID: 29440322 Free PMC article. Review.
-
The central role of mitochondria in axonal degeneration in multiple sclerosis.Mult Scler. 2014 Dec;20(14):1806-13. doi: 10.1177/1352458514544537. Epub 2014 Aug 13. Mult Scler. 2014. PMID: 25122475 Review.
-
Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis.Acta Neuropathol. 2020 Aug;140(2):143-167. doi: 10.1007/s00401-020-02179-x. Epub 2020 Jun 22. Acta Neuropathol. 2020. PMID: 32572598 Free PMC article.
-
Stressed cybrids model demyelinated axons in multiple sclerosis.Metab Brain Dis. 2013 Dec;28(4):639-45. doi: 10.1007/s11011-013-9410-6. Epub 2013 Apr 24. Metab Brain Dis. 2013. PMID: 23612782
Cited by
-
Compensatory Neuroprotective Response of Thioredoxin Reductase against Oxidative-Nitrosative Stress Induced by Experimental Autoimmune Encephalomyelitis in Rats: Modulation by Theta Burst Stimulation.Molecules. 2020 Aug 27;25(17):3922. doi: 10.3390/molecules25173922. Molecules. 2020. PMID: 32867364 Free PMC article.
-
Vitamin B1 Intake in Multiple Sclerosis Patients and its Impact on Depression Presence: A Pilot Study.Nutrients. 2020 Aug 31;12(9):2655. doi: 10.3390/nu12092655. Nutrients. 2020. PMID: 32878159 Free PMC article.
-
Promising Treatment for Multiple Sclerosis: Mitochondrial Transplantation.Int J Mol Sci. 2022 Feb 17;23(4):2245. doi: 10.3390/ijms23042245. Int J Mol Sci. 2022. PMID: 35216361 Free PMC article. Review.
-
Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms.Nat Commun. 2022 Dec 12;13(1):7670. doi: 10.1038/s41467-022-35357-4. Nat Commun. 2022. PMID: 36509784 Free PMC article.
-
On the Neuroprotective Role of Astaxanthin: New Perspectives?Mar Drugs. 2018 Jul 24;16(8):247. doi: 10.3390/md16080247. Mar Drugs. 2018. PMID: 30042358 Free PMC article. Review.